Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What is at stake in genetic newborn screening for rare diseases? - An exploratory qualitative study of parents' and expectant parents' concerns in the Screen4Care project.

Public health genomics·2026
Same author

Chung-Jansen Syndrome in a Young Woman with a PHIP Variant: Severe Obesity, Intellectual Disability, and Endocrine Abnormalities.

Journal of clinical medicine·2026
Same author

European Reference Networks as core health structures where referring genetic newborn screening positive infants: an innovative operational research framework.

Frontiers in public health·2026
Same author

CMR-derived left ventricular pressure-volume loops enhance individualized assessment of disease severity and prognosis in pulmonary arterial hypertension in adults.

Physiological reports·2026
Same author

Exploring Embryonic and Postnatal Gene Therapy Approaches for GJB2-Related Deafness: A Scoping Review.

Audiology research·2026
Same author

The Right Ventricle, the Forgotten Chamber or Not.

Magnetic resonance imaging clinics of North America·2026

Related Experiment Video

Updated: May 21, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Novel mutations in the SLC26A4 gene.

Micol Busi1, Alessandro Castiglione, Marina Taddei Masieri

  • 1Audiology Department - C.so Giovecca 203, 44121, University of Ferrara, Italy. bsumcl@unife.it

International Journal of Pediatric Otorhinolaryngology
|June 22, 2012
PubMed
Summary

Genetic testing of the SLC26A4 gene identified novel mutations in two Italian boys with hearing loss and enlarged vestibular aqueduct (EVA). This highlights the importance of comprehensive SLC26A4 sequencing for diagnosing deafness.

More Related Videos

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Related Experiment Videos

Last Updated: May 21, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Area of Science:

  • Genetics
  • Otolaryngology
  • Molecular Biology

Background:

  • Mutations in the SLC26A4 gene are a leading cause of genetic hearing loss, presenting as syndromic (Pendred Syndrome) or non-syndromic (DFNB4) deafness.
  • These conditions, often inherited as autosomal recessive traits, can be associated with inner ear malformations, most commonly enlarged vestibular aqueduct (EVA).
  • Identifying novel SLC26A4 variants is crucial for improving clinical assessment and diagnostic strategies for hearing loss.

Purpose of the Study:

  • To investigate the genetic basis of hearing loss in two unrelated Italian boys.
  • To identify and characterize new mutations within the SLC26A4 gene associated with hearing impairment and EVA.

Main Methods:

  • Clinical, audiological, and genetic evaluations were performed on the patients and their families.
  • Comprehensive DNA sequencing of the SLC26A4 gene, including all exons, intron-exon boundaries, and the promoter region, was conducted.

Main Results:

  • Both patients presented with congenital, progressive, and fluctuating mixed hearing loss and bilateral enlarged vestibular aqueduct (EVA).
  • Previously undescribed heterozygous mutations, R409H/IVS2+1delG and L236P/K590X, were identified in the SLC26A4 gene in the two probands.
  • No mutations were found in GJB2, GJB6 genes, or mitochondrial DNA.

Conclusions:

  • The novel IVS2+1delG and K590X mutations in SLC26A4 are suggested to have a pathological role in hearing loss.
  • Complete sequencing of the SLC26A4 gene is essential for the differential molecular diagnosis of deafness.
  • This study underscores the significance of SLC26A4 gene analysis in patients with congenital, progressive, fluctuating mixed hearing loss and bilateral EVA.